Generated by Llama 3.3-70B| Brian Kobilka | |
|---|---|
| Name | Brian Kobilka |
| Birth date | May 30, 1955 |
| Birth place | Little Falls, Minnesota, United States |
| Nationality | American |
| Fields | Biochemistry, Molecular biology |
| Institutions | Stanford University, Duke University, University of California, San Francisco |
Brian Kobilka is a renowned American Nobel laureate in chemistry, known for his groundbreaking work on G protein-coupled receptors (GPCRs) at Stanford University and Duke University. His research has significantly advanced our understanding of cell signaling pathways, involving proteins such as rhodopsin and beta-adrenergic receptor, and has far-reaching implications for the development of new pharmaceuticals by companies like Pfizer and Merck & Co.. Kobilka's work has been recognized by the National Academy of Sciences and the Institute of Medicine, and has collaborated with prominent scientists like Robert Lefkowitz and Alfred G. Gilman. He has also been involved in various research initiatives with National Institutes of Health and Howard Hughes Medical Institute.
Kobilka was born in Little Falls, Minnesota, and grew up in a family of Catholic Benedictine monks and nuns at St. John's Abbey and College of St. Benedict. He attended College of St. Benedict and later transferred to University of Minnesota Duluth, where he earned his bachelor's degree in biology and chemistry. Kobilka then pursued his graduate studies at Yale University, working under the supervision of Jesuit Patrick O. Brown and Robert J. Lefkowitz, and earned his Ph.D. in biochemistry from Yale University. During his time at Yale University, he was also influenced by the work of Harvard University researchers like Martin Rodbell and Alfred G. Gilman.
Kobilka began his academic career as a postdoctoral researcher at Duke University, working in the laboratory of Robert J. Lefkowitz, a renowned expert in G protein-coupled receptors. He later joined the faculty at Stanford University as an assistant professor of medicine and molecular and cellular physiology, and established his own research laboratory with funding from National Institutes of Health and American Heart Association. Kobilka's research group has collaborated with scientists from University of California, San Francisco, University of California, Los Angeles, and Massachusetts Institute of Technology, and has published numerous papers in top-tier journals like Nature and Science. He has also served on the editorial boards of Journal of Biological Chemistry and Proceedings of the National Academy of Sciences.
Kobilka's research has focused on the structure and function of G protein-coupled receptors (GPCRs), a large family of cell surface receptors that play critical roles in cell signaling pathways, including those involved in neurotransmission and hormone regulation. His laboratory has used X-ray crystallography and electron microscopy to determine the three-dimensional structures of GPCRs, including the beta-adrenergic receptor and rhodopsin, in collaboration with researchers from University of Cambridge and European Molecular Biology Laboratory. These studies have provided valuable insights into the mechanisms of G protein activation and receptor desensitization, and have implications for the development of new drugs targeting GPCRs, such as those developed by GlaxoSmithKline and AstraZeneca. Kobilka's work has also been influenced by the research of Eric Kandel and Arvid Carlsson, and has collaborated with scientists from Columbia University and Karolinska Institutet.
Kobilka has received numerous awards and honors for his contributions to the field of biochemistry and molecular biology, including the Nobel Prize in Chemistry in 2012, which he shared with Robert J. Lefkowitz. He has also been recognized with the Shaw Prize in 2010, the Wolf Prize in Medicine in 2012, and the Breakthrough Prize in Life Sciences in 2013. Kobilka is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences, and has received honorary degrees from University of Minnesota, Yale University, and Harvard University. He has also been awarded the Albert Lasker Award for Basic Medical Research and the Gairdner Foundation International Award.
Kobilka is married to Tong Sun Kobilka, a Chinese-American biochemist who has worked at Stanford University and University of California, San Francisco. He has two children, Jason Kobilka and Emily Kobilka, and enjoys hiking and fishing in his free time. Kobilka is also a Catholic and has spoken about the importance of his faith in his life and work, and has been involved in various Catholic organizations, including the Catholic Church and Knights of Columbus. He has also been involved in various philanthropic efforts, including the Bill and Melinda Gates Foundation and the Michael J. Fox Foundation.